Integrity Applications

GlucoTrack (Nasdaq:GCTK) announced today that its second-generation glucose monitor device has shown promising results in analyses.

Rutherford, New Jersey-based GlucoTrack — formerly known as Integrity Applications (Nasdaq:IGAP) — earlier this year completed lab testing of the non-invasive GlucoTrack 2.0 clinical prototype system and has observed better-than-expected accuracy and performance with the technology.

Get the full story at our sister site, Drug Delivery Business News.

Integrity Applications (Nasdaq:IGAP) announced today that it completed the change of its corporate name to GlucoTrack.

Rutherford, New Jersey-based GlucoTrack confirmed the change of its ticker symbol on the Nasdaq capital market to “GCTK,” which was made effective at the commencement of trading today, March 14, 2022.

Get the full story at our sister site, Drug Delivery Business News.